| List Name |
Annotation |
Enrichment |
p-value |
| response to hypoxia |
AmiGO Browser |
18.82 |
5.16e-03 |
| negative regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
6.04 |
0.01 |
| Mo-molybdopterin cofactor metabolic process |
AmiGO Browser |
50.57 |
0.02 |
| Mo-molybdopterin cofactor biosynthetic process |
AmiGO Browser |
50.57 |
0.02 |
| molybdopterin cofactor metabolic process |
AmiGO Browser |
50.57 |
0.02 |
| molybdopterin cofactor biosynthetic process |
AmiGO Browser |
50.57 |
0.02 |
| regulation of cyclic nucleotide biosynthetic process |
AmiGO Browser |
44.95 |
0.02 |
| regulation of cAMP metabolic process |
AmiGO Browser |
44.95 |
0.02 |
| regulation of nucleotide biosynthetic process |
AmiGO Browser |
44.95 |
0.02 |
| muscle contraction |
AmiGO Browser |
4.93 |
0.02 |
| postreplication repair |
AmiGO Browser |
40.45 |
0.02 |
| negative regulation of nucleotide metabolic process |
AmiGO Browser |
40.45 |
0.02 |
| regulation of DNA repair |
AmiGO Browser |
36.78 |
0.03 |
| neurotransmitter uptake |
AmiGO Browser |
36.78 |
0.03 |
| regulation of cyclic nucleotide metabolic process |
AmiGO Browser |
36.78 |
0.03 |
| positive regulation of gene-specific transcription |
AmiGO Browser |
33.71 |
0.03 |
| regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
2.89 |
0.03 |
| regulation of nucleotide metabolic process |
AmiGO Browser |
31.12 |
0.03 |
| pteridine and derivative biosynthetic process |
AmiGO Browser |
31.12 |
0.03 |
| aromatic compound biosynthetic process |
AmiGO Browser |
31.12 |
0.03 |
| embryonic organ morphogenesis |
AmiGO Browser |
31.12 |
0.03 |
| negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
3.39 |
0.03 |
| protein retention in ER |
AmiGO Browser |
28.90 |
0.03 |
| unfolded protein response |
AmiGO Browser |
26.97 |
0.04 |
| isoprenoid biosynthetic process |
AmiGO Browser |
26.97 |
0.04 |
| negative regulation of transcription, DNA-dependent |
AmiGO Browser |
4.16 |
0.04 |
| pteridine and derivative metabolic process |
AmiGO Browser |
25.28 |
0.04 |
| transcription from RNA polymerase II promoter |
AmiGO Browser |
2.43 |
0.04 |
| patterning of blood vessels |
AmiGO Browser |
22.47 |
0.04 |
| mammary gland development |
AmiGO Browser |
22.47 |
0.04 |
| negative regulation of cellular metabolic process |
AmiGO Browser |
3.02 |
0.05 |
| protein folding |
AmiGO Browser |
3.80 |
0.05 |
| vasoconstriction |
AmiGO Browser |
20.23 |
0.05 |
| ER-nuclear signaling pathway |
AmiGO Browser |
20.23 |
0.05 |
| cell aging |
AmiGO Browser |
19.26 |
0.05 |
| alkene biosynthetic process |
AmiGO Browser |
17.59 |
0.06 |
| leukotriene biosynthetic process |
AmiGO Browser |
17.59 |
0.06 |
| alkene metabolic process |
AmiGO Browser |
15.56 |
0.06 |
| leukotriene metabolic process |
AmiGO Browser |
15.56 |
0.06 |
| positive regulation of transcription, DNA-dependent |
AmiGO Browser |
3.30 |
0.06 |
| isoprenoid metabolic process |
AmiGO Browser |
14.98 |
0.06 |
| fibroblast growth factor receptor signaling pathway |
AmiGO Browser |
14.45 |
0.07 |
| cAMP biosynthetic process |
AmiGO Browser |
14.45 |
0.07 |
| negative regulation of metabolic process |
AmiGO Browser |
2.63 |
0.07 |
| embryonic organ development |
AmiGO Browser |
13.95 |
0.07 |
| mRNA catabolic process, nonsense-mediated decay |
AmiGO Browser |
13.48 |
0.07 |
| phospholipase C activation |
AmiGO Browser |
12.64 |
0.08 |
| eye morphogenesis |
AmiGO Browser |
12.26 |
0.08 |
| maintenance of cellular protein localization |
AmiGO Browser |
12.26 |
0.08 |
| neural crest cell development |
AmiGO Browser |
12.26 |
0.08 |
| neural crest cell differentiation |
AmiGO Browser |
12.26 |
0.08 |
| proteoglycan metabolic process |
AmiGO Browser |
12.26 |
0.08 |
| maintenance of protein localization |
AmiGO Browser |
11.90 |
0.08 |
| aging |
AmiGO Browser |
11.56 |
0.08 |
| maintenance of cellular localization |
AmiGO Browser |
11.24 |
0.09 |
| cAMP metabolic process |
AmiGO Browser |
10.93 |
0.09 |
| cholesterol biosynthetic process |
AmiGO Browser |
10.93 |
0.09 |
| glucose transport |
AmiGO Browser |
10.65 |
0.09 |
| mesenchymal cell development |
AmiGO Browser |
10.65 |
0.09 |
| mesenchymal cell differentiation |
AmiGO Browser |
10.37 |
0.09 |
| hexose transport |
AmiGO Browser |
10.11 |
0.09 |
| monosaccharide transport |
AmiGO Browser |
10.11 |
0.09 |
| negative regulation of transcription |
AmiGO Browser |
2.76 |
0.10 |
| positive regulation of transcription |
AmiGO Browser |
2.76 |
0.10 |
| mRNA catabolic process |
AmiGO Browser |
9.87 |
0.10 |
| embryonic pattern specification |
AmiGO Browser |
9.87 |
0.10 |
| icosanoid biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
| regulation of blood vessel size |
AmiGO Browser |
9.41 |
0.10 |
| cyclic nucleotide biosynthetic process |
AmiGO Browser |
9.41 |
0.10 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.70 |
0.10 |
L2L Microarray Analysis Tool